HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.39
Day range
$0.38 - $0.41
Year range
$0.27 - $0.82
Market cap
432.20M USD
Avg Volume
878.25K
P/E ratio
10.34
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 31.59M | 119.92% |
Operating expense | 3.94M | -21.53% |
Net income | 18.59M | 270.71% |
Net profit margin | 58.86 | 177.62% |
Earnings per share | — | — |
EBITDA | 9.40M | 514.31% |
Effective tax rate | 10.75% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.09M | 154.37% |
Total assets | 126.41M | 39.29% |
Total liabilities | 46.10M | -15.12% |
Total equity | 80.31M | — |
Shares outstanding | 1.08B | — |
Price to book | 5.57 | — |
Return on assets | 18.49% | — |
Return on capital | 29.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 18.59M | 270.71% |
Cash from operations | -5.28M | -396.23% |
Cash from investing | -206.07K | — |
Cash from financing | -33.64K | 82.58% |
Net change in cash | -5.52M | -339.06% |
Free cash flow | -8.09M | -754.54% |
About
Founded
1997
Headquarters
Website
Employees
68
